SPRINT-MS: A Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Activity of Ibudilast (MN-166) in Subjects with Progressive Multiple Sclerosis (NN 102)

Grant

Date/time Interval

  • April 14, 2014 - August 31, 2018
  • Total Award Amount

  • 9460.00
  • Direct Costs

  • 6435.00
  • Sponsor Award Id

  • Contributor

  • Bashir, Khurram   Principal Investigator  
  • Meador, William   Investigator  
  • Nabors M.D., Louis   Investigator  
  • Rinker II, John   Investigator  
  • Vaphiades, Michael   Investigator